Kornitzer Capital Management Inc. KS Acquires Shares of 40,000 Phreesia, Inc. $PHR

Kornitzer Capital Management Inc. KS bought a new position in shares of Phreesia, Inc. (NYSE:PHR) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 40,000 shares of the company’s stock, valued at approximately $941,000. Kornitzer Capital Management Inc. KS owned approximately 0.07% of Phreesia at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Loomis Sayles & Co. L P acquired a new position in Phreesia during the 2nd quarter valued at about $34,162,000. Capricorn Fund Managers Ltd bought a new position in shares of Phreesia in the third quarter valued at approximately $11,395,000. Cambiar Investors LLC purchased a new position in shares of Phreesia during the second quarter valued at approximately $10,674,000. Greenhouse Funds LLLP boosted its position in shares of Phreesia by 12.5% during the second quarter. Greenhouse Funds LLLP now owns 3,325,262 shares of the company’s stock valued at $94,637,000 after buying an additional 368,352 shares during the last quarter. Finally, Marshall Wace LLP grew its holdings in Phreesia by 205.4% during the second quarter. Marshall Wace LLP now owns 418,484 shares of the company’s stock worth $11,910,000 after buying an additional 281,454 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Phreesia from $32.00 to $29.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 9th. KeyCorp lowered their target price on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Wells Fargo & Company started coverage on shares of Phreesia in a research report on Thursday, January 8th. They set an “overweight” rating and a $30.00 price target on the stock. Robert W. Baird reduced their price objective on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a research report on Wednesday, December 10th. Finally, DA Davidson decreased their price objective on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research note on Friday, January 23rd. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $29.76.

Insider Buying and Selling

In other Phreesia news, insider Evan Roberts sold 6,268 shares of the business’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $102,544.48. Following the sale, the insider directly owned 826,554 shares in the company, valued at $13,522,423.44. The trade was a 0.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Balaji Gandhi sold 4,687 shares of the company’s stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $76,679.32. Following the transaction, the chief financial officer directly owned 150,569 shares in the company, valued at $2,463,308.84. This represents a 3.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 60,766 shares of company stock worth $1,013,817 in the last three months. Insiders own 5.50% of the company’s stock.

Phreesia Price Performance

Shares of NYSE:PHR opened at $14.67 on Thursday. The company has a market capitalization of $884.15 million, a P/E ratio of -146.64 and a beta of 0.61. The company’s 50-day moving average is $17.41 and its 200 day moving average is $22.59. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. Phreesia, Inc. has a fifty-two week low of $14.65 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The company’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.25) earnings per share. On average, equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.